Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer

Objectives: The purpose of the present study was to evaluate the prognostic value of a systemic immune-inflammation index (SII) and the relationship between SII and the effectiveness of postoperative treatment in patients with non-small cell lung cancer (NSCLC). Methods: A total of 538 patients diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xue, Li, Guowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103585/
https://www.ncbi.nlm.nih.gov/pubmed/32175568
http://dx.doi.org/10.1042/BSR20200352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103585/
https://www.ncbi.nlm.nih.gov/pubmed/32175568
http://dx.doi.org/10.1042/BSR20200352

Ejemplares similares